Medicus Pharma (MDCX) Shares Outstanding (2023 - 2025)

Medicus Pharma has reported Shares Outstanding for 3 years, with the latest figure at $25.2 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 113.06% year-over-year to $25.2 million; the trailing twelve-month figure through Dec 2025 stood at $25.2 million (up 113.06% YoY), and the FY2025 full-year result was $25.2 million, up 113.06% from the prior year.
• Shares Outstanding for Q4 2025 stood at $25.2 million, up from $21.0 million in the prior quarter.
• The five-year high for Shares Outstanding was $25.2 million in Q4 2025, with the low at $8.1 million in Q4 2023.
• Historically, Shares Outstanding has averaged $14.4 million across 3 years, with a median of $11.8 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding surged 46.31% — and 2025, when it surged 113.06%.
• Medicus Pharma's Shares Outstanding stood at $8.1 million in 2023, then surged by 46.31% to $11.8 million in 2024, then jumped by 113.06% to $25.2 million in 2025.
• The last three Shares Outstanding figures came in at $25.2 million (Q4 2025), $21.0 million (Q3 2025), and $15.9 million (Q2 2025), per Business Quant data.